I
Igentify
Digital platform for genetic tests providers
About Igentify
Igentify is a digital health startup that operates in the rapidly growing field of genomics. The company has developed a secure digital platform that simplifies the entire genomic workflow. In simpler terms, it helps patients, laboratories, and healthcare providers to access, understand, and use genetic information more effectively.
Read full description
The platform serves a diverse range of clients, including individual patients seeking to understand their genetic makeup, laboratories conducting genetic testing, and healthcare providers who need to interpret and apply genetic information in patient care.
Igentify operates in the global genomics market, which is expected to grow significantly due to increasing awareness about the potential of genetic information in disease prevention and personalized medicine.
The business model of Igentify is likely based on a software-as-a-service (SaaS) model, where clients pay a subscription fee to access the platform and use its features. This model provides a steady stream of recurring revenue for the company.
In terms of revenue generation, Igentify likely makes money through subscription fees from laboratories and healthcare providers. It may also generate revenue from individual patients who use the platform to access and interpret their genetic information.
In conclusion, Igentify is a promising startup in the genomics field, offering a digital platform that simplifies the use of genetic information for a wide range of clients.
At a glance
- Status
- Operational
- Founded
- 2016
- Headquarters
- Haifa, Israel
- Employees
- 42
- Open positions
- None listed
- Dealroom signal
- 58.3/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Personal Health, Testing, Biotechnology, DNA, Genetics and genomics, Health Information, Screening, Health Diagnostics, Spinout
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCOther financing | Sep 2019 | $11M | $42M | OurCrowd · aMoon Fund | — |
| SPINOUTOther financing | Jan 2016 | $0 | — | Technion Israel Institute of Technology | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Igentify is 9.7K monthly website visits, up 115.6% over the last three months. Igentify's team declined 17.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
OurCrowd
aMoon Fund
Other known investors2 additional known investors
Technion Israel Institute of Technology- SVSilverTech Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Igentify on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Igentify’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.